Chi George 4
4 · CASI Pharmaceuticals, Inc. · Filed Oct 2, 2018
Insider Transaction Report
Form 4
Chi George
Chief Financial Officer
Transactions
- Award
Stock Options (Right to Buy)
2018-09-28+400,000→ 400,000 totalExercise: $4.67Exp: 2028-09-28→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The stock options vest as follows: 25% on each of the first, second, third and fourth anniversary of the date of grant.